Cancer remains the second-leading cause of death globally. As the incidence of cancer increases with age, its prevalence is unfortunately linked to the ageing of the world's population. While advances are being made, the needs and markets for solutions remain large, creating investment opportunities. Candriam's roughly two decades of experience in Biotech investing provide the specialized scientific and investment skills necessary to benefit from these investment opportunities.